Clinical Trial Update: A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis [EARLY_Phase 1]

View source ↗

Summary

A prospective, single-center, open-label Phase 1 trial evaluating inhaled BMD003 (CFTR mRNA) in adult Chinese patients with cystic fibrosis; the study is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• BMD003 (CFTR mRNA)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cystic Fibrosis (CF), Gene Therapy | EARLY_Phase 1 | Status: NOT_YET_RECRUITING